Roche’s oral SERD delays early breast cancer recurrence in late-stage trialnews2025-11-18T12:08:53+00:00November 18th, 2025|Endpoints News|
Lifordi gets new funding from Sanofi as it preps to test ADC in rheumatoid arthritisnews2025-11-18T12:00:59+00:00November 18th, 2025|Endpoints News|
Thrivory raises $3.5M to help clinics get paid upfront within secondsnews2025-11-18T12:00:35+00:00November 18th, 2025|Endpoints News|
Boston biotech AI Proteins raises $42M Series A round for miniproteinsnews2025-11-18T12:00:31+00:00November 18th, 2025|Endpoints News|
Vanda says its drug can halve vomiting risk in patients using GLP-1snews2025-11-18T11:57:39+00:00November 18th, 2025|Endpoints News|
Drugmakers say HHS’ 340B pilot is limited as they fight for their own rebate modelsnews2025-11-17T21:00:33+00:00November 17th, 2025|Endpoints News|
Zymeworks and Jazz tout HER2 bispecific success in first Phase 3 readoutnews2025-11-17T20:44:06+00:00November 17th, 2025|Endpoints News|
New US trade deal caps Switzerland, Liechtenstein pharma tariffs at 15%news2025-11-17T19:14:06+00:00November 17th, 2025|Endpoints News|
Novo Nordisk lowers self-pay prices for weight loss drugs ahead of Lilly, TrumpRxnews2025-11-17T18:22:42+00:00November 17th, 2025|Endpoints News|
Scholar Rock plans to launch spinal muscular atrophy drug next yearnews2025-11-17T17:48:23+00:00November 17th, 2025|Endpoints News|
